Bone markers in the management of metastatic bone disease.
about
Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid.The pharmacokinetics and pharmacodynamics of denosumab in patients with advanced solid tumours and bone metastases: a systematic reviewPhase II studies of two different schedules of dasatinib in bone metastasis predominant metastatic breast cancer: SWOG S0622Diagnostic and prognostic validity of serum bone turnover markers in bone metastatic non-small cell lung cancer patientsBone resorption predicts for skeletal complications in metastatic bone diseaseElevated serum P1NP predicts development of bone metastasis and survival in early-stage breast cancer.Quantitative pharmacology of denosumab in patients with bone metastases from solid tumors.Serum cross-linked N-telopeptide of type I collagen for the diagnosis of bone metastases from solid tumours in the Chinese population: Meta-analysis.Concurrent use of strontium-89 with external beam radiotherapy for multiple bone metastases: early experience.A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer.Bone metastases in patients with small cell lung carcinoma: rate of development, early versus late onset, modality of treatment, and their impact on survival. A single-institution retrospective cohort study.Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid.How can bone turnover markers be best utilized for prediction of skeletal events in patients with solid tumors?
P2860
Q34026943-EE19A13A-5AF9-4EC0-9CC7-A64A30EDFC8FQ34571005-DD85054D-3527-4934-8E5B-053773AA8949Q36090747-381B0C7B-CA40-4CC3-98CB-D630D55E3481Q36289997-42770895-6C61-4D94-A1FD-FFC67E6BA056Q36648116-B6DE93BF-0797-460E-AEB3-DA43509653C0Q37402732-06181728-55FF-4B3D-B9E6-96D2FF45A712Q38364467-7F58FA7B-4A41-4E1C-B4ED-8F074606E9B2Q38382963-C126A17E-D1C3-4221-B66C-4D11C7DAD5E3Q38565304-14CD869A-8065-4F61-8AAD-9E7CDE9964ECQ38693661-12FB6163-78B2-4277-A620-72EFCE44EAE9Q48719655-3181A4BA-D287-407C-B20D-EF41A155CF18Q51060059-CBBD80CE-CE11-4737-A4FD-D4970A583925Q53272212-6D309764-77B3-4CF7-BFEE-94F868840AA5
P2860
Bone markers in the management of metastatic bone disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bone markers in the management of metastatic bone disease.
@ast
Bone markers in the management of metastatic bone disease.
@en
Bone markers in the management of metastatic bone disease.
@nl
type
label
Bone markers in the management of metastatic bone disease.
@ast
Bone markers in the management of metastatic bone disease.
@en
Bone markers in the management of metastatic bone disease.
@nl
prefLabel
Bone markers in the management of metastatic bone disease.
@ast
Bone markers in the management of metastatic bone disease.
@en
Bone markers in the management of metastatic bone disease.
@nl
P2093
P356
P1476
Bone markers in the management of metastatic bone disease.
@en
P2093
P304
P356
10.1053/CTRV.2000.0212
P577
2001-06-01T00:00:00Z